[Skip to Content]
[Skip to Content Landing]
Article
May 1936

NEOARSPHENAMINE IN THE TREATMENT OF NONSYPHILITIC INFLAMMATIONS OF THE UVEAL TRACT

Author Affiliations

CHEYENNE, WYO.

Arch Ophthalmol. 1936;15(5):826-832. doi:10.1001/archopht.1936.00840170038004
Abstract

Acute inflammations of the iris and ciliary body of determinate origin usually respond readily to the specific therapy indicated. Most of those of obscure etiology respond favorably to the injection of nonspecific foreign protein, the administration of salicylates and the standard local application of heat and mydriatics. Some of the acute forms and numerous chronic forms of iridocyclitis and uveitis of indeterminate origin do not respond to any type of treatment. The prognosis in these, under the most satisfactory conditions, is unfavorable. S. R. Gifford,1 in a review of the etiology of acute iritis including his own contribution on 118 cases, showed that the etiologic factor can be determined, on the average, in only 78 per cent of the cases.

In 1887, H. Gifford2 advocated the use of large doses of sodium salicylate in the treatment of sympathetic ophthalmia. Since then this method has become

×